These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. ZFYVE26/SPASTIZIN and SPG11/SPATACSIN mutations in hereditary spastic paraplegia types AR-SPG15 and AR-SPG11 have different effects on autophagy and endocytosis. Vantaggiato C; Panzeri E; Castelli M; Citterio A; Arnoldi A; Santorelli FM; Liguori R; Scarlato M; Musumeci O; Toscano A; Clementi E; Bassi MT Autophagy; 2019 Jan; 15(1):34-57. PubMed ID: 30081747 [TBL] [Abstract][Full Text] [Related]
5. Loss of spastin function results in disease-specific axonal defects in human pluripotent stem cell-based models of hereditary spastic paraplegia. Denton KR; Lei L; Grenier J; Rodionov V; Blackstone C; Li XJ Stem Cells; 2014 Feb; 32(2):414-23. PubMed ID: 24123785 [TBL] [Abstract][Full Text] [Related]
6. Pharmacologic rescue of axon growth defects in a human iPSC model of hereditary spastic paraplegia SPG3A. Zhu PP; Denton KR; Pierson TM; Li XJ; Blackstone C Hum Mol Genet; 2014 Nov; 23(21):5638-48. PubMed ID: 24908668 [TBL] [Abstract][Full Text] [Related]
7. A hereditary spastic paraplegia mouse model supports a role of ZFYVE26/SPASTIZIN for the endolysosomal system. Khundadze M; Kollmann K; Koch N; Biskup C; Nietzsche S; Zimmer G; Hennings JC; Huebner AK; Symmank J; Jahic A; Ilina EI; Karle K; Schöls L; Kessels M; Braulke T; Qualmann B; Kurth I; Beetz C; Hübner CA PLoS Genet; 2013; 9(12):e1003988. PubMed ID: 24367272 [TBL] [Abstract][Full Text] [Related]
9. Direct evidence for axonal transport defects in a novel mouse model of mutant spastin-induced hereditary spastic paraplegia (HSP) and human HSP patients. Kasher PR; De Vos KJ; Wharton SB; Manser C; Bennett EJ; Bingley M; Wood JD; Milner R; McDermott CJ; Miller CC; Shaw PJ; Grierson AJ J Neurochem; 2009 Jul; 110(1):34-44. PubMed ID: 19453301 [TBL] [Abstract][Full Text] [Related]
10. Rescue axonal defects by targeting mitochondrial dynamics in hereditary spastic paraplegias. Mou Y; Li XJ Neural Regen Res; 2019 Apr; 14(4):574-577. PubMed ID: 30632492 [TBL] [Abstract][Full Text] [Related]
11. ATPase-deficient mitochondrial inner membrane protein ATAD3A disturbs mitochondrial dynamics in dominant hereditary spastic paraplegia. Cooper HM; Yang Y; Ylikallio E; Khairullin R; Woldegebriel R; Lin KL; Euro L; Palin E; Wolf A; Trokovic R; Isohanni P; Kaakkola S; Auranen M; Lönnqvist T; Wanrooij S; Tyynismaa H Hum Mol Genet; 2017 Apr; 26(8):1432-1443. PubMed ID: 28158749 [TBL] [Abstract][Full Text] [Related]
12. Monitoring Axonal Degeneration in Human Pluripotent Stem Cell Models of Hereditary Spastic Paraplegias. Li XJ; Mou Y; Milton C; Chen Z Methods Mol Biol; 2022; 2549():69-83. PubMed ID: 33772460 [TBL] [Abstract][Full Text] [Related]
13. Aβ-Induced Drp1 phosphorylation through Akt activation promotes excessive mitochondrial fission leading to neuronal apoptosis. Kim DI; Lee KH; Gabr AA; Choi GE; Kim JS; Ko SH; Han HJ Biochim Biophys Acta; 2016 Nov; 1863(11):2820-2834. PubMed ID: 27599716 [TBL] [Abstract][Full Text] [Related]
14. A novel Drp1 inhibitor diminishes aberrant mitochondrial fission and neurotoxicity. Qi X; Qvit N; Su YC; Mochly-Rosen D J Cell Sci; 2013 Feb; 126(Pt 3):789-802. PubMed ID: 23239023 [TBL] [Abstract][Full Text] [Related]
15. [A case of spastic paraplegia 48 with a novel mutation in the AP5Z1 gene]. Maruta K; Ando M; Otomo T; Takashima H Rinsho Shinkeigaku; 2020 Aug; 60(8):543-548. PubMed ID: 32641631 [TBL] [Abstract][Full Text] [Related]